Begelomab (SAND-26) is a murine monoclonal antibody targeting DPP-4/CD26. Begelomab can be used to study severe refractory inflammatory myopathies and drug-resistant acute graft-versus-host disease.
Purity:
95.00%
CAS Number:
[1403744-56-8]
Target:
Proteasome|||DPP-4
* VAT and and shipping costs not included. Errors and price changes excepted